Roden — July 7, 2021 — Mycobacterium abscessus is a
PureIMS preparing for Series A financing round aiming to bring
PureIMS expands leadership with Bram van Dijck, MBA, as new CEO whilst intensifying late-stage programs strategy
Roden — November 20, 2020 — PureIMS, a clinical stage
Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops® High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
I. Sibum, P. Hagedoorn, C.O. Botterman, H.W. Frijlink and F.